Veeva Systems (NYSE:VEEV) Upgraded to Buy at Wall Street Zen

Key Points

• Wall Street Zen upgraded Veeva Systems to “buy” from “hold,” joining a generally positive analyst consensus. Nineteen analysts rate the stock a Buy, with a consensus “Moderate Buy” rating and an average price target of $284.88.
• Veeva reported quarterly EPS of $2.35, exceeding the $2.23 estimate, while revenue rose 17.6% year over year to $927.96 million. The company’s growth outlook is supported by continued Vault CRM adoption, AI product expansion and growing biotech customer penetration.
• Shares opened at $296.15, near their 52-week high, with a market value of approximately $48 billion and a P/E ratio of 48.71. Despite strong institutional ownership, recent insider selling and valuation concerns suggest limited near-term upside and potential profit-taking risk.

Veeva Systems (NYSE:VEEV - Get Free Report) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a note issued to investors on Saturday, Wall Street Zen reports.

Several other brokerages have also issued reports on VEEV. Morgan Stanley lifted their price objective on shares of Veeva Systems from $215.00 to $275.00 and gave the company an "equal weight" rating in a report on Thursday, August 27th. UBS Group upped their target price on Veeva Systems from $190.00 to $290.00 and gave the stock a "neutral" rating in a report on Thursday, August 27th. Citigroup increased their target price on Veeva Systems from $190.00 to $273.00 and gave the company a "neutral" rating in a research report on Friday, August 28th. Needham & Company LLC lifted their price target on Veeva Systems from $270.00 to $310.00 and gave the company a "buy" rating in a report on Thursday, August 27th. Finally, Robert W. Baird boosted their price target on Veeva Systems from $260.00 to $300.00 and gave the stock an "outperform" rating in a research report on Thursday, August 27th. Nineteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $284.88.

Veeva Systems Price Performance

VEEV stock opened at $296.15 on Friday. Veeva Systems has a 1-year low of $148.05 and a 1-year high of $302.17. The business has a 50-day moving average price of $261.01 and a 200 day moving average price of $203.58. The company has a market capitalization of $47.95 billion, a P/E ratio of 48.71, a PEG ratio of 1.22 and a beta of 0.93.

Veeva Systems (NYSE:VEEV - Get Free Report) last issued its earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $0.12. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. The company had revenue of $927.96 million for the quarter, compared to analysts' expectations of $905.38 million. During the same period in the prior year, the business earned $1.99 EPS. The firm's quarterly revenue was up 17.6% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, analysts anticipate that Veeva Systems will post 6.70 earnings per share for the current fiscal year.

Insider Activity at Veeva Systems

In other Veeva Systems news, EVP Daniel Rizzo sold 4,841 shares of the firm's stock in a transaction that occurred on Friday, October 2nd. The shares were sold at an average price of $276.51, for a total value of $1,338,584.91. Following the completion of the sale, the executive vice president directly owned 7,665 shares in the company, valued at $2,119,449.15. This trade represents a 38.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Thomas Schwenger sold 10,000 shares of the company's stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $281.33, for a total value of $2,813,300.00. Following the transaction, the insider directly owned 19,449 shares in the company, valued at approximately $5,471,587.17. The trade was a 33.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 51,591 shares of company stock valued at $13,355,945 over the last 90 days. Insiders own 10.60% of the company's stock.

Institutional Investors Weigh In On Veeva Systems

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Principal Financial Group Inc. grew its stake in shares of Veeva Systems by 7.0% during the first quarter. Principal Financial Group Inc. now owns 4,141,545 shares of the technology company's stock worth $727,513,000 after acquiring an additional 271,252 shares during the last quarter. Swedbank AB raised its position in shares of Veeva Systems by 43.5% in the 1st quarter. Swedbank AB now owns 1,645,128 shares of the technology company's stock valued at $288,983,000 after purchasing an additional 498,971 shares during the last quarter. Pictet Asset Management Holding SA raised its position in shares of Veeva Systems by 43.6% in the 1st quarter. Pictet Asset Management Holding SA now owns 1,593,795 shares of the technology company's stock valued at $279,970,000 after purchasing an additional 483,720 shares during the last quarter. Amundi boosted its stake in Veeva Systems by 8.0% in the 1st quarter. Amundi now owns 992,977 shares of the technology company's stock worth $174,426,000 after purchasing an additional 73,510 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its stake in Veeva Systems by 203.0% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 913,281 shares of the technology company's stock worth $160,427,000 after purchasing an additional 611,868 shares in the last quarter. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Key Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva’s strong second-quarter results, continued Vault CRM migrations and expansion of AI products support expectations for sustained growth. The company’s software remains deeply embedded in pharmaceutical and biotech workflows, creating customer retention and cross-selling opportunities. Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
• Positive Sentiment: Veeva highlighted new AI capabilities, including Veeva Falcon and Vault AI, along with enhancements to its Development Cloud and Quality Cloud applications. These tools could increase the value of its platform as drug developers seek faster research, clinical-trial and quality processes. Veeva Systems Showcases AI Innovations
• Positive Sentiment: Veeva Basics has reached nearly 200 customers and the company is drawing attention after reaching approximately 175 biotech customers, signaling adoption among emerging biopharma companies and a potentially broader long-term customer base. Veeva Basics Customer Update
• Positive Sentiment: Market commentary identifies Veeva as one of the software companies benefiting from institutional buying after earlier fears that AI could make subscription software obsolete. Its sticky customer data and strong switching costs are viewed as competitive advantages. Wall Street Left Software for Dead
• Neutral Sentiment: Evercore ISI raised its price target from $185 to $250, but that target is below the stock’s recent trading level, suggesting analysts may see less near-term upside after the rally. Evercore ISI Adjusts Veeva Price Target
• Negative Sentiment: Investors remain concerned that market saturation could limit growth, while valuation-focused analysis estimates the shares may be roughly 11% above fair value based on future cash generation. Veeva’s sharp advance also leaves the stock vulnerable to profit-taking if adoption or earnings momentum slows. Veeva Stock May Be Below Fair Value

Veeva Systems Company Profile

Veeva Systems Inc is a cloud software company that provides applications and services for the life sciences industry. Its customers include pharmaceutical, biotechnology, medical device and other organizations involved in developing, manufacturing and commercializing regulated products.

The company's product portfolio includes the Veeva Vault platform, which supports areas such as clinical operations, regulatory affairs, quality management, safety and medical communications. Veeva also offers commercial and customer relationship management applications, data and analytics products, and services designed to help life sciences companies manage relationships with healthcare professionals, oversee content and improve operational efficiency.

Founded in 2007, Veeva serves customers globally and has expanded its offerings from commercial software into research, development, manufacturing and quality processes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.